A Study to Evaluate Virtual Remote Control Robotic Percutaneous Coronary Intervention

Overview

About this study

The purpose of this study is to evaluate whether or not robotic percutaneous coronary interventin (PCI) can be performed safely and effectively with the primary operator located in an adjacent control room using a remote control telecommunications system.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients (> 18 years old) undergoing elective planned percutaneous coronary intervention (PCI) of one coronary artery territory.
  • Target coronary lesion is suitable for robotic PCI at discretion of the primary operator.
  • Either femoral or radial approach planned for procedure.
  • Patient must be able to tolerate dual antiplatelet therapy and give written informed consent.

Exclusion Criteria:

  • Hemodynamic instability, cardiogenic shock or anticipated need for hemodynamic support device use.
  • Severely calcified coronary lesion or anticipated need for rotational atherectomy.
  • Chronic total occlusion.
  • Unrevascularized multivessel coronary artery disease.
  • Left ventricular ejection fraction < 35%.
  • Advanced renal dysfunction (defined as GFR < 30 ml/min).

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mackram Eleid, M.D.

Contact us for the latest status

Contact information:

Diana Albers B.S.

(507)255-6884

Albers.Diana2@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20476328

Mayo Clinic Footer